Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

STADA ARZNEIMITTEL

(SAZ)
 SummaryNewsCompany 
Company
STADA Arzneimittel AG (STADA) is a global pharmaceutical company that focuses on multisource products. Its product portfolio is concentrated on active ingredients, which are free of patent restriction. It focuses on three core business segments: Generics offers drugs in the multisource product category, made from readily available, off-patent active ingredients; Brand-Name Products focuses on multisource products... 
Sector
Pharmaceuticals
Calendar
-
More about the company
All news about STADA ARZNEIMITTEL
03/03DGAP-AFR  : STADA Arzneimittel AG: Preliminary announcement of the publication o..
DJ
2020STADA ARZNEIMITTEL  : Every 2nd European does not know their vaccination status
PU
2020DIGITAL DOCTORS : Europeans open to apps on prescription
PU
2020Enzymatica and STADA extend agreement on ViruProtect to Russia, Poland, Ukrai..
AQ
2020STADA ARZNEIMITTEL AG : Preliminary announcement of the publication of financial..
EQ
2020XBRANE BIOPHARMA PUBL  : has completed a directed share issue and thereby raises..
AQ
2020STADA ARZNEIMITTEL : Ex-dividend day for final dividend
FA
2020Bausch + lomb licenses exclusive rights from stada and xbrane to a biosimilar..
AQ
2020Xbrane and STADA partner with Bausch + Lomb for commercialization of Xlucane ..
AQ
2020STADA ARZNEIMITTEL AG : Preliminary announcement of the publication of financial..
EQ
2020EXCLUSIVE : Germany's Stada buys 15 GSK consumer health brands
RE
2020STADA ARZNEIMITTEL AG : Release of the Home Member State according to Article 5 ..
EQ
2020STADA ARZNEIMITTEL  : to acquire established OTC and food supplement portfolio i..
PU
2020STADA ARZNEIMITTEL  : Wolfgang Ollig to become new CFO of the STADA Group
PU
2019STADA ARZNEIMITTEL  : to Become a Major Pharma Player in Ukraine by Acquiring Bi..
PU
More news
News in other languages on STADA ARZNEIMITTEL
03/31PETER GOLDSCHMIDT : Stada verlängert mit Chef Goldschmidt - grösserer Vorstand
03/30Stada führt Biosimilar von Roche-Krebsmedikament Avastin ein
03/11Übernahmen treiben Stada an - gedämpfte Arznei-Nachfrage in Pandemie
03/08Arzneikonzern Stada steigt in Cannabis-Markt ein
03/08GESUND WEGEN CORONA-REGELN :  Verkauf von Erkältungsmitteln bricht ein
More news
Analyst Recommendations on STADA ARZNEIMITTEL
More recommendations
Managers and Directors
NameTitle
Peter Goldschmidt Chairman-Executive Board
Wolfgang Ollig Chief Financial Officer
Günter von Au Chairman-Supervisory Board
Miguel Pagan Fernandez Chief Technical Officer
Jens Steegers Member-Supervisory Board
Sector and Competitors